---
title: "The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236896078.md"
description: "The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI, Xizang Weixinkang Pharmaceutical, and Well Pharmaceutical hitting the daily limit, while Salubris, Hengrui Pharma, and Dongcheng Biochem had the largest gains"
datetime: "2025-04-22T05:39:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236896078.md)
  - [en](https://longbridge.com/en/news/236896078.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236896078.md)
generator: "portal-rs"
---

# The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI hitting the daily limit

The biopharmaceutical sector continued to rise in the afternoon, with FUSHILAI, Xizang Weixinkang Pharmaceutical, and Well Pharmaceutical hitting the daily limit, while Salubris, Hengrui Pharma, and Dongcheng Biochem had the largest gains

### Related Stocks

- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [002675.CN](https://longbridge.com/en/quote/002675.CN.md)
- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)
- [603351.CN](https://longbridge.com/en/quote/603351.CN.md)
- [002294.CN](https://longbridge.com/en/quote/002294.CN.md)
- [301258.CN](https://longbridge.com/en/quote/301258.CN.md)

## Related News & Research

- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [REG - Bankers Investment - Monthly Factsheet as at 31 July 2026](https://longbridge.com/en/news/296783775.md)
- [Carlsberg supervisory board member Jens Hjorth buys Carlsberg shares](https://longbridge.com/en/news/296996512.md)
- [REG - Henderson HighIncome - Monthly Factsheet as at 31 July 2026](https://longbridge.com/en/news/296783757.md)
- [16:00 ETCHRIS HEMSWORTH JOINS ARCHIE ROSE DISTILLING CO. AS CO-OWNER AHEAD OF U.S. LAUNCH AND GLOBAL EXPANSION](https://longbridge.com/en/news/296950819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**